Insulin decreases circulating vitamin E levels in humans

Metabolism: Clinical and Experimental

Volumn 45, Issue 8, 1996, Pages 998-1003

  Galvan, Alfredo Quiñones ^b   Muscelli, Elza ^b   Catalano, Carlo ^b   Natali, Andrea ^b   Sanna, Giovanna ^b   Masoni, Antonio ^b   Bernardini, Barbara ^b   Barsacchi, Renata ^b   Ferrannini, Ele ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN INFUSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0029787477     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90270-X     Document Type: Article

References (47)

1. Pyöräla K, Savolainen E, Kaukola S, et al: Plasma insulin as coronary heart disease risk factor: Relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinky Policemen Study population. Acta Med Scand 70:38-52, 1985
2. Ducimetiere P, Eschwege E, Papoz L, et al: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
3. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154-160, 1979
4. Ferrannini E, Stern MP: Primary insulin resistance: A risk syndrome, in Leslie RDG, Robbins D (eds): Diabetes: Clinical Science in Practice. Cambridge UK, Cambridge University Press, 1995, pp 200-220
5. Levy RI, Feinleb MD: Risk factors for coronary artery disease and their management, in Brawnwald E (ed): Heart Disease. A Textbook of Cardiovascular Medicine (ed 2). Philadelphia, PA, Saunders, 1984, pp 1205-1234
6. Laakso M, Sarlund H, Salonen R, et al: Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 11:1068-1076, 1991
7. Halliwell B: The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23:118-126, 1993
8. Witzum JL: The oxidation hypothesis of atherosclerosis. Lancet 344:793-795, 1994
9. Steinberg D, Parthasarathy S, Carew TE, et al: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
10. Goldstein JL, Ho YK, Basu SK, et al: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-337, 1979
11. Mitchinson MJ, Ball RY: Macrophages and atherogenesis. Lancet 2:146-148, 1987
12. Steinberg D: Antioxidants in the prevention of human atherosclerosis. Circulation 85:2338-2344, 1992
13. Dieber-Rothender M, Puhl H, Waeg G, et al: Effect of oral supplementation with D-alfa-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32:1325-1332, 1991
14. Rimm EB, Stampfer MJ, Ascherio A, et al: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450-1456, 1993
15. Stampfer MJ, Hennekens CH, Manson JE, et al: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444-1449, 1993
16. Gillery P, Monboissde J-C, Maquart F-X: Does oxygen free radical increased formation explain long term complications of diabetes mellitus? Med Hypotheses 29:47-50, 1989
17. Maggi E, Marchesi E, Ravetta V, et al: Low-density lipopro-tein oxidation in essential hypertension. J Hypertens 11:1103-1111, 1993
18. Mullarkey CJ, Edelstein D, Brownlee M: Free radical generation by early glycation products: A mechanism for accelerated atherosclerosis in diabetes. Biochem Biophys Res Commun 173:932-939, 1990
19. Noronha-Dutra AA, Epperlein MM, Woolf N: Effect of cigarette smoking on cultured human endothelial cells. Cardiovasc Res 27:774-778, 1993
20. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
21. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med 153:154-183, 1993
22. McGuire EAH, Heldermann JH, Tobin JD, et al: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:1312-1318, 1976
23. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E233, 1979
24. Lang JK, Gohil R, Packer L: Simultaneous determination of tocopherols, ubiquinols and ubiquinones in blood, plasma tissue and subcellular fractions. Anal Biochem 15:106-116, 1986
25. 3 fractions after polyanion precipitation: A comparison between chemical extractive and totally enzymatic procedures. Clin Chim Acta 146:81-86, 1985
26. Roeschlau P, Bernt T, Gruber W: Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem 12:226-227, 1974
27. Wahlefeld AW: Triglycerides determination after enzymatic hydrolysis, in Bergmeyer HU (ed): Methods of Enzymatic Analysis. San Diego, CA, Academic, 1974, pp 1831-1835
28. De Long DM, De Long ER, Wood PD, et al: A comparison of methods for the estimation of low and very low density lipoprotein cholesterol: The Lipid Research Clinics Prevalence Study. JAMA 256:2372-2377, 1986
29. Ferrannini E, Smith JD, Cobelli C, et al: Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 76:357-364, 1985
30. Tappy L, Owen OE, Boden G: Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37:1212-1216, 1988
31. Meydani M: Vitamin E. Lancet 345:170-175, 1995
32. Esterbauer H, Striegl G, Puhl H, et al: The role of vitamin E and carotenoids in preventing oxidation of low density lipoprotein. Ann NY Acad Sci 570:254-267, 1989
33. Jialal I, Grundy S: Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 33:899-906, 1992
34. Machlin LJ: Vitamin E, in Machlin LJ (ed): Handbook of Vitamins. Nutritional, Biochemical and Clinical Aspects. New York, NY, 1984, pp 99-144
35. Mazzone T, Foster D, Chait A: In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 33:333-338, 1984
36. Baynes C, Henderson AD, Richmond W, et al: The response of hepatic lipase and serum lipoproteins to acute hyperinsulinemia in type 2 diabetes. Eur J Clin Invest 22:341-346, 1992
37. Bounder J, Kager L, Ostman J, et al: Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32:117-123, 1983
38. Gey KF, Puska P: Plasma vitamin E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci 570:268-282, 1989
39. De Bono DP: Free radicals and antioxidants in vascular biology: The roles of reaction kinetics, environment and substrate turnover. Q J Med 87:445-453, 1994
40. Thurnam D, Davies A, Crump R, et al: The use of different lipids to express serum tocopherol:lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 23:514-520, 1986
41. Vuilleumier JP, Keller HE, Gysel D, et al: Clinical methods for the routine assessment of the vitamin status in human populations. I. The fat soluble vitamins A and E and β-carotene. Int J Vitam Nutr Res 53:265-272, 1983
42. Borkman M, Storlien LH, Pan DA, et al: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-441, 1993
43. Habib MP, Dickerson FD, Mooradian AD: Effect of diabetes, insulin and glucose load on lipid peroxidation in the rat. Metabolism 43:1442-1445, 1994
44. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 89:1006-1013, 1992
45. Krempf M, Ranganathan S, Ritz P, et al: Plasma vitamin A and E in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) adult diabetic patients. Int J Vitam Nutr Res 61:38-42, 1991
46. Paolisso G, D'Amore A, Giuliano D, et al: Pharmacological doses of vitamin E improve insulin action in healthy subjects and non-insulin dependent diabetic patients. Am J Clin Nutr 57:650-656, 1993
47. Paolisso G, D'Amore A, Volpe C, et al: Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 43:1426-1429, 1994